Hamilton Receives CE Mark for Transport Ventilator With Neonatal Option

Hamilton Medical AG has received the CE Mark and released in the European Union the Hamilton-T1 transport ventilator with neonatal option. The system offers the same capabilities found in full featured neonatal ICU ventilators, but in a mobile format for use in a variety of situations.

The system is based on the Hamilton-T1 ventilator, but with hardware and software modifications to suit neonatal patients, including support for tidal volumes down to 2 ml. The system continuously measures the pressure, volume, and flow proximal to the patient, constantly adjusting the flow to prevent dead space ventilation and synchronizing with natural breathing cycles, the company claims. The new nCPAP-PC (pressure control) mode lets clinicians set a CPAP target, with the system then automatically adjusting the flow to compensate to the patient’s unique status.

Demand flow technology allows the patient to receive only as much flow as is necessary to obtain the set CPAP target. This reduces WOB, reduces the need for user interventions and ensures optimal leak compensation. Clinicians also will require less oxygen for transport and noise caused by the ventilator decreases distinctively.

The Hamilton-T1’s built-in turbine makes it completely independent of compressed air, gas cylinders or compressors. This saves weight and space and even noninvasively ventilated neonates can be transported over long distances. The combination of a built-in and an optional hot-swappable battery provides a battery operation of more than nine hours. This can be extended indefinitely with additional hot-swappable batteries.

Based in Switzerland, Hamilton Medical is a global ventilation solution provider present in over 100 countries worldwide with offices in Birmingham, United Kingdom; Shanghai, China; and Reno, Nev. The company was founded in 1983.